Left bundle branch block management strategy: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Left bundle branch block}} | {{Left bundle branch block}} | ||
{{CMG}}; {{AE}} {{CZ}} | {{CMG}}; {{AE}} {{CZ}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== |
Revision as of 15:25, 7 February 2013
Left bundle branch block Microchapters |
Differentiating Left Bundle Branch Block from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Left bundle branch block management strategy On the Web |
American Roentgen Ray Society Images of Left bundle branch block management strategy |
Risk calculators and risk factors for Left bundle branch block management strategy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Treatment is directed at the underlying cause of left bundle branch block, such as ST elevation myocardial infarction. Patients with syncope and LBBB may have a rhythm disturbance that requires a pacemaker. Given the dysynchrony that occurs with left ventricular contractility, cardiac resynchronization therapy in heart failure patients may be of benefit.